Nalfurafine
- Level
- Commodity
- Parent
- 51372000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51372018This classification denotes an opioid receptor agonist with the molecular formula C28H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XC41AVD567, chemically known as (e)-n-(17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl)-3-(furan-3-yl)-n-methylprop-2-enamide but generally known as nalfurafine, which bears US NIH Compound Identifier 6445230. European Medicines Agency schedules Nalfurafine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25222. The term NALFURAFINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 2, 2003, List 49). World Health Organization schedules nalfurafine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule nalfurafine under HS 29391900 and SITC 54141. As of Q4 2014, NALFURAFINE remains the US FDA Preferred Term for this commodity. Nalfurafine bears US NLM identifiers UMLS ID C2825264 and NCI Concept Code C80585. SMILES: O1C2C34C(O)(C(N(CC3)CC3CC3)CC3C4C1C(O)CC3)CCC2N(C)C(=O)/C=C/C1CCOC1.
Same parent
Under 51372000 · 42Activities that produce or sell this
KBLI · 8Inherited from family 51370000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.